Adaptimmune Therapeutics PLC (ADAPY) stock
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Adaptimmune Therapeutics's total debt was $25.68M at Jun 30, 2025. For fiscal 2024 it was $50.24M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $50.24M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $25.68M | +2.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $25.41M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $50.24M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $49.87M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $24.95M | – |
See a number that looks wrong?